Kadsurin A exhibits significant anti-inflammatory and immunomodulatory activities, making it a compound of interest in the development of therapeutics for chronic inflammatory diseases. It has been studied for its ability to inhibit key signaling pathways such as NF-κB, which plays a central role in regulating the immune response to infection and inflammation. Due to this mechanism, Kadsurin A is being explored for potential use in treating autoimmune conditions like rheumatoid arthritis and inflammatory bowel disease.

Additionally, it demonstrates antiviral properties, particularly against certain strains of herpesviruses, suggesting possible application in antiviral drug research. Its natural origin and bioactivity also make it a candidate for use in traditional medicine standardization and phytochemical-based drug discovery. Ongoing research focuses on enhancing its bioavailability and evaluating its efficacy in preclinical models.